Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Evidence-Based Metrics and Other Multidimensional Considerations in Promotion or Tenure Evaluations in Academic Psychiatry.

Kenna H, Swanson AN, Roberts LW.

Acad Psychiatry. 2017 Aug;41(4):467-470. doi: 10.1007/s40596-017-0741-1. Epub 2017 Jun 22. No abstract available.

PMID:
28643140
2.

Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease.

Wroolie TE, Kenna HA, Williams KE, Rasgon NL.

Am J Geriatr Psychiatry. 2015 Nov;23(11):1117-26. doi: 10.1016/j.jagp.2015.05.009. Epub 2015 May 21.

3.

Lamotrigine and GABAA receptor modulators interact with menstrual cycle phase and oral contraceptives to regulate mood in women with bipolar disorder.

Robakis TK, Holtzman J, Stemmle PG, Reynolds-May MF, Kenna HA, Rasgon NL.

J Affect Disord. 2015 Apr 1;175:108-15. doi: 10.1016/j.jad.2014.12.040. Epub 2014 Dec 24.

4.

Association between insulin resistance and cognition in patients with depressive disorders: exploratory analyses into age-specific effects.

Wroolie TE, Kenna HA, Singh MK, Rasgon NL.

J Psychiatr Res. 2015 Jan;60:65-72. doi: 10.1016/j.jpsychires.2014.10.001. Epub 2014 Oct 14.

PMID:
25455511
5.

Decreased hypothalamic functional connectivity with subgenual cortex in psychotic major depression.

Sudheimer K, Keller J, Gomez R, Tennakoon L, Reiss A, Garrett A, Kenna H, O'Hara R, Schatzberg AF.

Neuropsychopharmacology. 2015 Mar;40(4):849-60. doi: 10.1038/npp.2014.259. Epub 2014 Oct 8.

6.

Optimistic outlook regarding maternity protects against depressive symptoms postpartum.

Robakis TK, Williams KE, Crowe S, Kenna H, Gannon J, Rasgon NL.

Arch Womens Ment Health. 2015 Apr;18(2):197-208. doi: 10.1007/s00737-014-0446-3. Epub 2014 Aug 5.

7.

Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy.

Rasgon NL, Kenna HA, Wroolie TE, Williams KE, DeMuth BN, Silverman DH.

Psychiatry Res. 2014 Jul 30;223(1):28-36. doi: 10.1016/j.pscychresns.2014.04.004. Epub 2014 Apr 15.

PMID:
24819305
8.

From networking to next-working: how an academic department "retreated" and advanced at the same time.

Yager J, Kenna H, Hantke M.

Acad Psychiatry. 2015 Apr;39(2):220-4. doi: 10.1007/s40596-014-0139-2. Epub 2014 May 2.

PMID:
24789482
9.

Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia.

Rasgon NL, Geist CL, Kenna HA, Wroolie TE, Williams KE, Silverman DH.

PLoS One. 2014 Mar 12;9(3):e89095. doi: 10.1371/journal.pone.0089095. eCollection 2014.

10.

Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol.

Yuen KW, Garner JP, Carson DS, Keller J, Lembke A, Hyde SA, Kenna HA, Tennakoon L, Schatzberg AF, Parker KJ.

J Psychiatr Res. 2014 Apr;51:30-6. doi: 10.1016/j.jpsychires.2013.12.012. Epub 2013 Dec 28.

PMID:
24405552
11.

Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women.

Kenna HA, Reynolds-May M, Stepanenko A, Ketter TA, Hallmayer J, Rasgon NL.

J Affect Disord. 2014 Mar;156:214-8. doi: 10.1016/j.jad.2013.01.054. Epub 2013 Dec 21.

12.

Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls.

Reynolds-May MF, Kenna HA, Marsh W, Stemmle PG, Wang P, Ketter TA, Rasgon NL.

Bipolar Disord. 2014 Feb;16(1):37-47. doi: 10.1111/bdi.12149. Epub 2013 Nov 22.

13.

High rates of comorbid depressive and anxiety disorders among women with premutation of the FMR1 gene.

Kenna HA, Tartter M, Hall SS, Lightbody AA, Nguyen Q, de los Angeles CP, Reiss AL, Rasgon NL.

Am J Med Genet B Neuropsychiatr Genet. 2013 Dec;162B(8):872-8. doi: 10.1002/ajmg.b.32196. Epub 2013 Sep 3.

14.

Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use.

Jacobs EG, Kroenke C, Lin J, Epel ES, Kenna HA, Blackburn EH, Rasgon NL.

PLoS One. 2013;8(2):e54713. doi: 10.1371/journal.pone.0054713. Epub 2013 Feb 13.

15.

Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease.

Kenna H, Hoeft F, Kelley R, Wroolie T, DeMuth B, Reiss A, Rasgon N.

Neurobiol Aging. 2013 Mar;34(3):641-9. doi: 10.1016/j.neurobiolaging.2012.06.006. Epub 2012 Jul 6.

16.

Psychiatric complications of treatment with corticosteroids: review with case report.

Kenna HA, Poon AW, de los Angeles CP, Koran LM.

Psychiatry Clin Neurosci. 2011 Oct;65(6):549-60. doi: 10.1111/j.1440-1819.2011.02260.x. Review.

17.

Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.

Wroolie TE, Kenna HA, Williams KE, Powers BN, Holcomb M, Khaylis A, Rasgon NL.

Am J Geriatr Psychiatry. 2011 Sep;19(9):792-802. doi: 10.1097/JGP.0b013e3181ff678a.

18.

Gender-specific lipid profiles in patients with bipolar disorder.

Vemuri M, Kenna HA, Wang PW, Ketter TA, Rasgon NL.

J Psychiatr Res. 2011 Aug;45(8):1036-41. doi: 10.1016/j.jpsychires.2011.02.002. Epub 2011 Mar 4.

PMID:
21377167
19.

Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline.

Lin J, Kroenke CH, Epel E, Kenna HA, Wolkowitz OM, Blackburn E, Rasgon NL.

Brain Res. 2011 Mar 16;1379:224-31. doi: 10.1016/j.brainres.2010.10.033. Epub 2010 Oct 18.

20.

Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD.

Silverman DH, Geist CL, Kenna HA, Williams K, Wroolie T, Powers B, Brooks J, Rasgon NL.

Psychoneuroendocrinology. 2011 May;36(4):502-13. doi: 10.1016/j.psyneuen.2010.08.002. Epub 2010 Sep 1.

21.

Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus.

Rasgon NL, Kenna HA, Reynolds-May MF, Stemmle PG, Vemuri M, Marsh W, Wang P, Ketter TA.

Bipolar Disord. 2010 Aug;12(5):504-13. doi: 10.1111/j.1399-5618.2010.00839.x.

22.

Preliminary evidence that plasma oxytocin levels are elevated in major depression.

Parker KJ, Kenna HA, Zeitzer JM, Keller J, Blasey CM, Amico JA, Schatzberg AF.

Psychiatry Res. 2010 Jul 30;178(2):359-62. doi: 10.1016/j.psychres.2009.09.017. Epub 2010 May 21.

23.

Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders?

McIntyre RS, Kenna HA, Nguyen HT, Law CW, Sultan F, Woldeyohannes HO, Adams AK, Cheng JS, Lourenco M, Kennedy SH, Rasgon NL.

Adv Ther. 2010 Feb;27(2):63-80. doi: 10.1007/s12325-010-0011-z. Review.

PMID:
20390390
24.

Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study.

Rasgon NL, Kenna HA, Williams KE, Powers B, Wroolie T, Schatzberg AF.

ScientificWorldJournal. 2010 Feb 19;10:321-8. doi: 10.1100/tsw.2010.32.

25.

Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.

Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, Brooks J, Williams KE, Powers BN, Hallmayer J, Reiss A.

Neurobiol Aging. 2011 Nov;32(11):1942-8. doi: 10.1016/j.neurobiolaging.2009.12.005. Epub 2009 Dec 23.

26.

Genetic overlap between polycystic ovary syndrome and bipolar disorder: the endophenotype hypothesis.

Jiang B, Kenna HA, Rasgon NL.

Med Hypotheses. 2009 Dec;73(6):996-1004. doi: 10.1016/j.mehy.2008.12.056. Epub 2009 Jun 24.

PMID:
19556071
27.

Reproductive and metabolic abnormalities associated with bipolar disorder and its treatment.

Kenna HA, Jiang B, Rasgon NL.

Harv Rev Psychiatry. 2009;17(2):138-46. doi: 10.1080/10673220902899722. Review.

PMID:
19373621
28.

Cerebral metabolic patterns in untreated postmenopausal women with major depressive disorder.

Rasgon NL, Kenna HA, Geist C, Small G, Silverman D.

Psychiatry Res. 2008 Oct 30;164(1):77-80. doi: 10.1016/j.pscychresns.2007.12.006. Epub 2008 Aug 15.

PMID:
18707852
29.

Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study.

Wroolie TE, Kenna HA, Williams KE, Powers BN, Holcomb M, Lazzeroni L, Rasgon NL.

Acta Neurol Scand. 2009 Mar;119(3):172-9. doi: 10.1111/j.1600-0404.2008.01084.x. Epub 2008 Aug 14.

PMID:
18705678
30.

Thalamo-Basal Ganglia connectivity in postmenopausal women receiving estrogen therapy.

Kenna HA, Rasgon NL, Geist C, Small G, Silverman D.

Neurochem Res. 2009 Feb;34(2):234-7. doi: 10.1007/s11064-008-9756-z. Epub 2008 Jun 6.

PMID:
18535904
31.

Insulin resistance and hyperlipidemia in women with bipolar disorder.

Stemmle PG, Kenna HA, Wang PW, Hill SJ, Ketter TA, Rasgon NL.

J Psychiatr Res. 2009 Jan;43(3):341-3. doi: 10.1016/j.jpsychires.2008.04.003. Epub 2008 May 19. No abstract available.

PMID:
18490029
32.

Dissociable intrinsic connectivity networks for salience processing and executive control.

Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, Reiss AL, Greicius MD.

J Neurosci. 2007 Feb 28;27(9):2349-56.

33.

Hypothalamic-pituitary-end organ function in women with bipolar depression.

Rasgon NL, Kenna HA, Wong ML, Whybrow PC, Bauer M.

Psychoneuroendocrinology. 2007 Apr;32(3):279-86. Epub 2007 Feb 20.

PMID:
17317022
34.

Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus.

Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H, Reiss AL, Schatzberg AF.

Biol Psychiatry. 2007 Sep 1;62(5):429-37. Epub 2007 Jan 8.

35.

Mood and neuropsychological changes in women with midlife depression treated with escitalopram.

Wroolie TE, Williams KE, Keller J, Zappert LN, Shelton SD, Kenna HA, Reynolds MF, Rasgon NL.

J Clin Psychopharmacol. 2006 Aug;26(4):361-6.

PMID:
16855452
36.

The neuropsychological profile of psychotic major depression and its relation to cortisol.

Gomez RG, Fleming SH, Keller J, Flores B, Kenna H, DeBattista C, Solvason B, Schatzberg AF.

Biol Psychiatry. 2006 Sep 1;60(5):472-8. Epub 2006 Feb 17.

PMID:
16483550
37.

Cortisol circadian rhythm alterations in psychotic major depression.

Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH, Schatzberg AF.

Biol Psychiatry. 2006 Aug 1;60(3):275-81. Epub 2006 Feb 3.

PMID:
16458262
38.

Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis.

Rasgon NL, Kenna HA.

Neurobiol Aging. 2005 Dec;26 Suppl 1:103-7. Epub 2005 Oct 11. Review.

PMID:
16225963
39.

Detecting psychotic major depression using psychiatric rating scales.

Keller J, Gomez RG, Kenna HA, Poesner J, DeBattista C, Flores B, Schatzberg AF.

J Psychiatr Res. 2006 Feb;40(1):22-9. Epub 2005 Sep 13.

PMID:
16165160
40.

Clinical and biological effects of mifepristone treatment for psychotic depression.

Flores BH, Kenna H, Keller J, Solvason HB, Schatzberg AF.

Neuropsychopharmacology. 2006 Mar;31(3):628-36.

Supplemental Content

Support Center